Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Screening for prostate cancer: the current position.

S M Moss1, J Melia

  • 1Cancer Screening Evaluation Unit, Institute of Cancer Research, Sutton, Surrey, UK.

British Medical Bulletin
|June 15, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The impact of mammography screening programmes on incidence of advanced breast cancer in Europe: a literature review.

BMC cancer·2018
Same author

FIT for the future: a case for risk-based colorectal cancer screening using the faecal immunochemical test.

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2016
Same author

GPs views and understanding of PSA testing, screening and early detection; survey.

International journal of clinical practice·2016
Same author

Prostate-specific antigen testing rates and referral patterns from general practice data in England.

International journal of clinical practice·2016
Same author

Cost-effectiveness of prostate cancer screening: a simulation study based on ERSPC data.

Journal of the National Cancer Institute·2014
Same author

Comparison of the performance of HPV tests in women with abnormal cytology: results of a study within the NHS cervical screening programme.

Cytopathology : official journal of the British Society for Clinical Cytology·2014
Same journal

Augmentation in Achilles tendon repair: evidence versus enthusiasm.

British medical bulletin·2026
Same journal

Regional musculoskeletal pain in workers-is the traditional medical model increasing disability?

British medical bulletin·2026
Same journal

Human health in relation to visible, functional, and accessible green space: a systematic review and narrative synthesis of the 3 + 30 + 300 guideline.

British medical bulletin·2026
Same journal

Muscle herniae in exercise-induced leg pain: diagnostic pitfalls and the 'repair paradox'.

British medical bulletin·2026
Same journal

Scaffolds and platelet concentrates in bone regenerative medicine: applications, mechanisms, and future approaches.

British medical bulletin·2026
Same journal

Back squat and deadlift fatiguing protocols elicit distinct countermovement jump profiles: phase-specific predictors and soreness responses.

British medical bulletin·2026
See all related articles

Prostate cancer screening shows promise for early detection but lacks evidence of reducing mortality. Current population screening is not recommended due to concerns about over-diagnosis and treatment effectiveness.

Area of Science:

  • Urology
  • Oncology
  • Public Health

Background:

  • Prostate cancer presents a growing health challenge globally, particularly in the UK.
  • Screening for prostate cancer is of significant interest to detect the disease early.
  • Prostate-specific antigen (PSA) testing is a leading screening method.

Purpose of the Study:

  • To evaluate the effectiveness of prostate cancer screening.
  • To determine if screening reduces prostate cancer mortality.
  • To address concerns regarding over-diagnosis and treatment efficacy.

Main Methods:

  • Review of current prostate cancer screening tests, focusing on PSA levels.
  • Analysis of evidence regarding the impact of screening on early-stage disease detection.

Related Experiment Videos

  • Consideration of potential harms, including over-diagnosis and treatment morbidity.

    • Main Results:

    • Screening detects asymptomatic, early-stage prostate cancer.
    • No current evidence demonstrates that screening reduces prostate cancer mortality.
    • Concerns exist about over-diagnosis of indolent or slow-growing cancers.

    Conclusions:

    • Population-based prostate cancer screening is not currently recommended.
    • Ongoing randomized controlled trials are necessary to definitively assess screening effectiveness.
    • Results from these trials are expected in the distant future.